TechnoDerma Medicines Inc.

TechnoDerma Medicines Inc.

Private
ChengduHealthcare & Life Scienceshttps://www.technodermamed.com/en/

Last Round

Early Funding

Jan 15, 2024

Company Overview

TechnoDerma Medicines Inc. is a clinical-stage biopharmaceutical company that develops innovative drugs for the treatment of androgenic alopecia, eczema/atopic dermatitis, psoriasis, and lupus.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Government Contracts, Services & Consulting

AI Layer

Non-AI

Keywords

small-molecule drugsdermatology therapeuticshair loss treatmentandrogenetic alopeciatopical drugsmale pattern baldnessclinical-stage biotechhair regrowthdrug discoveryfirst-in-class drugsatopic dermatitiseczema treatmentpsoriasis treatmentthyromimeticclinical trialspharma licensinglupus treatmentscar treatment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

TechnoDerma Medicines Inc. Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

TechnoDerma Medicines Inc. Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Early FundingJan 15, 2024
Series A ExtensionJan 13, 2023
Series AApr 7, 2021

TechnoDerma Medicines Inc. Investors

Notable investors and investment history

InvestorRounds
CDH InvestmentsSeries A
Oceanpine CapitalSeries A
Viva BioInnovatorSeries A Extension, Early Funding, Series A

TechnoDerma Medicines Inc. Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

TechnoDerma Medicines Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about TechnoDerma Medicines Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersChengdu
Year Founded2010
Last FundingJan 15, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.